\u3ci\u3eParamecium bursaria\u3c/i\u3e Chlorella Virus 1 Proteome Reveals Novel Architectural and Regulatory Features of a Giant Virus by Dunigan, David et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Virology Papers Virology, Nebraska Center for 
6-2012 
Paramecium bursaria Chlorella Virus 1 Proteome Reveals Novel 
Architectural and Regulatory Features of a Giant Virus 
David Dunigan 
University of Nebraska-Lincoln, ddunigan2@unl.edu 
Ronald Cerny 
University of Nebraska-Lincoln, rcerny1@unl.edu 
Andrew T. Bauman 
Ocean Biologics, Seattle, WA 
Jared C. Roach 
Institute of Systems Biology, Seattle, WA 
Leslie C. Lane 
University of Nebraska-Lincoln, llane1@unl.edu 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/virologypub 
 Part of the Virology Commons 
Dunigan, David; Cerny, Ronald; Bauman, Andrew T.; Roach, Jared C.; Lane, Leslie C.; Agarkova, Irina V.; 
Wulser, Kurt William; Yanai-Balser, Giane M.; Gurnon, James R.; Vitek, Jason C.; Kronschnabel, Bernard J.; 
Jeannard, Adrien; Blanc, Guillaume; Upton, Chris; Duncan, Garry; McClung, O. William; Ma, Fangrui; and 
Van Etten, James L., "Paramecium bursaria Chlorella Virus 1 Proteome Reveals Novel Architectural and 
Regulatory Features of a Giant Virus" (2012). Virology Papers. 226. 
https://digitalcommons.unl.edu/virologypub/226 
This Article is brought to you for free and open access by the Virology, Nebraska Center for at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Virology Papers by an 
authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
David Dunigan, Ronald Cerny, Andrew T. Bauman, Jared C. Roach, Leslie C. Lane, Irina V. Agarkova, Kurt 
William Wulser, Giane M. Yanai-Balser, James R. Gurnon, Jason C. Vitek, Bernard J. Kronschnabel, Adrien 
Jeannard, Guillaume Blanc, Chris Upton, Garry Duncan, O. William McClung, Fangrui Ma, and James L. Van 
Etten 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
virologypub/226 
Page 1 of 47 
 
Title:  Paramecium bursaria Chlorella Virus 1 Proteome Reveals Novel Architectural and 1 
Regulatory Features of a Giant Virus 2 
David D. Dunigan# (1, 2), Ronald L. Cerny (3), Andrew T. Bauman (4), Jared C. Roach (5), 3 
Leslie C. Lane (1),  Irina V. Agarkova (1, 2), Kurt Wulser (3), Giane M. Yanai-Balser (1), James 4 
R. Gurnon (1), Jason C.Vitek (1), Bernard J. Kronschnabel (1), Adrien Jeannard (6), Guillaume 5 
Blanc (6), Chris Upton (7), Garry A. Duncan (8), O. William McClung (8), Fangrui Ma (2), 6 
James L. Van Etten# (1, 2) 7 
1Department of Plant Pathology, University of Nebraska-Lincoln, Lincoln, NE 68583-0900, 8 
USA; 9 
 2Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583-0900, 10 
USA;  11 
3Department of Chemistry, University of Nebraska-Lincoln, Lincoln, NE 68588-0304, USA;  12 
4Ocean Biologics, Seattle, WA 98133, USA 13 
5Institute of Systems Biology, Seattle, WA  98103, USA; 14 
6Structural and Genomic Information Laboratory, UMR7256 CNRS, Aix-Marseille University, 15 
Marseille, FR-13385, France  16 
7Department of Biochemistry and Microbiology, University of Victoria, Victoria, British 17 
Columbia, Canada; 18 
8Department of Biology, Nebraska Wesleyan University, Lincoln, NE 68504-2794, USA 19 
Running title: PBCV-1 virion proteome 20 
Key words:  Chlorella, Phycodnaviridae, large dsDNA virus, protein mass-spectrometry 21 
Abstract: 174 words 22 
Text: 7,017 words 23 
#Corresponding authors: David Dunigan, email:  ddunigan2@unl.edu and James L. Van Etten, 24 
email: jvanetten1@unl.edu 25 
 Copyright © 2012, American Society for Microbiology. All Rights Reserved.
J. Virol. doi:10.1128/JVI.00907-12 
JVI Accepts, published online ahead of print on 13 June 2012
Page 2 of 47 
 
ABSTRACT  26 
The 331 kilobase pairs chlorovirus PBCV-1 genome was re-sequenced and 27 
annotated to correct errors in the original 15 year old sequence; forty codons was 28 
considered the minimum protein size of an open reading frame.  PBCV-1 encodes 416 29 
predicted protein encoding sequences and 11 tRNAs.  A proteome analysis was also 30 
conducted on highly purified PBCV-1 virions using two mass-spectrometry based 31 
protocols.  The mass spectrometry-derived data were compared to PBCV-1 and its host 32 
Chlorella variabilis NC64A predicted proteomes.  Combined, these analyses revealed 33 
148 unique virus-encoded proteins associated with the virion (about 35% of the coding 34 
capacity of the virus) and one host protein.  Some of these proteins appear to be 35 
structural/architectural, whereas others have enzymatic, chromatin modification and 36 
signal transduction functions.  Most (106) of these proteins have no known function or 37 
homologs in the existing gene databases except as orthologs with other chloroviruses, 38 
phycodnaviruses and nuclear-cytoplasmic large DNA viruses.  The genes encoding these 39 
proteins are dispersed throughout the virus genome and most are transcribed late or early-40 
late in the infection cycle, which is consistent with virion morphogenesis. 41 
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INTRODUCTION 42 
Complex cellular and viral processes are modular and accomplished by the 43 
concerted action of functional modules.  One of the important functional modules of a 44 
virus is the virion particle, which ranges in complexity from a single type protein and 45 
small nucleic acid (e.g., tomato bushy stunt virus) to having dozens of types of proteins 46 
and lipids, along with a large nucleic acid genome (e. g., poxviruses).  Regardless, 47 
whether “simple” or complex in composition, all virions carry the legacy of their 48 
progenitors through encapsidation, release and stabilization.  Virions facilitate 49 
propagation of progeny through a series of tightly regulated biochemical steps, called the 50 
immediate-early phase of infection, which includes attachment, penetration, uncoating of 51 
the viral genome, intracellular trafficking of the viral genome to its replication center, and 52 
augmentation of cellular functions to “accept” the exotic nucleic acid/replicon.  The 53 
architectural elements of virions tend to be prominent, but studies on the supergroup 54 
nucleocytoplasmic large DNA viruses (NCLDV) (7, 37, 43) indicate that in addition to 55 
structural components, these virions perform multiple enzymatic and regulatory functions 56 
that are partitioned among several proteins.  The purpose of this study was to determine 57 
the virion proteome of Paramecium bursaria chlorella virus 1 (PBCV-1), a member of 58 
the NCLDV (11, 54).   59 
PBCV-1 is the type member of the genus Chlorovirus (family Phycodnaviridae) 60 
that infects certain chlorella-like green algae from fresh water sources; these viruses are 61 
found throughout the world (54, 56).  The chlorovirus host algae are normally symbionts 62 
of aquatic protists, and in this state are resistant to virus infection.  Nevertheless, virus 63 
titers from natural sources have been measured as high as 105 plaque forming units (pfu) 64 
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per ml; however, titers fluctuate with the season (58, 61).  Very little is known about the 65 
role chloroviruses play in freshwater ecology (41), but susceptible hosts lyse within 6-16 66 
hours in the laboratory and burst sizes typically exceed 102 pfu per cell (54, 56).  Thus, 67 
chloroviruses have the potential to alter microbial communities both quantitatively and 68 
qualitatively, as well as act as a driving force for microbial evolution (11).  Fortunately, 69 
some of the host algae can be grown in the laboratory independent of their co-symbiotic 70 
protists. 71 
The 331 kilobase pair (kbp) PBCV-1 dsDNA genome was sequenced and 72 
annotated about 15 years ago (26) and reported to have 689 open reading frames (ORF) 73 
of at least 65 codons.  Of these 689 ORFs, 377 were predicted to encode proteins (CDS); 74 
PBCV-1 also encoded 11 tRNAs (reviewed in 21, 55, 57).  The size of PBCV-1 extends 75 
beyond its coding capacity; the virion is a T = 169d quasi-icosahedral particle with a 76 
diameter of 190 nm across the 5-fold axis (63, 64) and has an estimated molecular mass 77 
of greater than 1 x 109 Da (53).  The virion is ~64% protein consisting of at least 40 78 
polypeptides, as seen on one dimensional SDS-PAGE (42).  The particle contains 5-10% 79 
lipid, which is associated with a bi-layered membrane underneath an outer glycoprotein 80 
shell (5, 42, 64). 81 
The capsid structure consists of the major capsid protein (MCP, Vp54), which is 82 
glycosylated at 6 sites (31) and is myristylated at least at one site (36).  Vp54 complexes 83 
with itself, and perhaps other proteins, to form homotrimeric capsomers that are 84 
responsible for the planar features of the capsid.  Initially it was assumed that, except for 85 
the 12 vertices, Vp54 was the only protein contributing to the external capsid and 5040 86 
copies of Vp54 were predicted per virion (64).  However, recent studies indicate that the 87 
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PBCV-1 virion is more complex than previously thought.  i) PBCV-1 contains a unique 88 
vertex with a 560-Å-long spike structure, which protrudes 340 Å from the surface of the 89 
virus.  The part of the spike structure that is outside of the capsid has an external diameter 90 
of 35 Å at the tip, expanding to 70 Å at the base.  The spike structure widens to 160 Å 91 
inside the capsid and forms a closed cavity inside a large pocket between the capsid and 92 
membrane enclosing the virus DNA (5, 66).  The related chlorovirus CVK1 has a virion-93 
associated protein Vp130 (homolog of PBCV-1 A140/145R) that binds to algal cell walls 94 
and is located at a unique vertex (34, 35), suggesting this protein is associated with the 95 
spike structure.  ii) Regularly spaced appendages occurring on the surface of the virion 96 
are present at approximately 1 per trisymmetron (66).  These appendages probably assist 97 
in attaching the virion to its host cell (56).  iii) The volume of the capsomers at the 98 
common vertices and those surrounding the spike structure at the unique vertex differ 99 
significantly, suggesting they consist of different proteins (5, 66).  iv) At least one vertex 100 
region may have a retractable appendage, such that when probed with a scanning atomic 101 
force stylet the structure retracts, but then resets much like a plunger with a spring (23).  102 
It is not known if this plunger is at the unique spike structure vertex or one of the other 11 103 
vertices.  v) Six minor capsid proteins of varying stochiometries support the particle 104 
architecture and appear to interact with the internal membrane in both the tri- and 105 
pentasymmetron structures, as observed with an 8.5 Å resolution map of the virion (66).  106 
Of these,  a “long protein” (~32 kDa) with similarity to the PRD1 bacteriophage long 107 
glue proteins forms an hexagonal network over the internal surface of the trisymmetrons, 108 
and a “membrane protein” dimer (~28 kDa) is located at the edge of the trisymmetrons 109 
and is connected to the internal membrane (1, 8).  vi) PBCV-1 DNA binding proteins 110 
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were evaluated with proteomic methods from isolated viral DNA of virions (59).  Six 111 
proteins were identified that have high isoelectric points that are well suited for binding 112 
and neutralization of DNA.  Thus, PBCV-1 structure has both symmetric and asymmetric 113 
elements, adding to the complexity of the virus morphology. 114 
vii) In addition to these structural features, PBCV-1 contains several functions 115 
that initiate infection.  PBCV-1 attaches specifically to its host Chlorella variabilis 116 
NC64A.  Thus, we predict one or more surface proteins of the virus mediate attachment; 117 
it is probably the spike structure (66).  Immediately upon PBCV-1 attachment, the cell 118 
wall is degraded at the site of attachment.  viii) Virions contain cell wall degrading 119 
activity (28, 62).  ix) Within the first minutes of infection the cell membrane depolarizes 120 
(12, 32), leaving the cell with significantly altered secondary transporter functions (2).  121 
This activity is hypothesized to be partially due to a PBCV-1-encoded K+ channel, Kcv 122 
(A250R) (27); however, no direct evidence supports the presence of Kcv in the virion.  x) 123 
In the first five min of infection host DNA begins to degrade and this is likely due to the 124 
two virus-encoded DNA restriction endonucleases [R.CviAI (A579L), R.CviAII 125 
(A252R)] packaged in PBCV-1 virions (3).  Host chromatin degradation begins before 126 
viral transcripts appear.  PBCV-1 DNA is resistant to the restriction enzymes because it is 127 
methylated.  xi) The next major intracellular event is the synthesis of early viral 128 
transcripts, observed 5-10 min p.i. (67; Blanc et al., unpublished data), which apparently 129 
occurs by pirating the cellular transcriptional machinery, because the virus does not 130 
encode a recognizable RNA polymerase gene and no polymerase activity was detected in 131 
virion-derived extracts (Jon Rohozinski and James Van Etten, unpublished results).  132 
The purpose of the current study is to evaluate the total viral complement of 133 
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proteins associated with the PBCV-1 virion using proteomic technologies and to re-134 
examine the structural/architectural features of this virus, as well as the initial events of 135 
infection in the context of the protein complement.  This evaluation led to the re-136 
sequencing of the PBCV-1 genome after preliminary proteomic analyses suggested there 137 
were errors in the PBCV-1 genome sequence (26).  This report presents the newly revised 138 
PBCV-1 genome and annotations, and proteomic analyzes of the infectious particles.  139 
MATERIALS AND METHODS 140 
Virus, cells, and culture conditions.  Procedures for growing virus PBCV-1 in 141 
the alga C. variabilis have been described (3, 52, 53).  142 
Virus purification scheme.  The virus was purified essentially as described (52) 143 
with the following modifications.  Prior to sucrose density gradient separation, the virus-144 
cell lysate (2 liters) was clarified by incubating with 1% (v/v) NP-40 detergent at room 145 
temperature for 1 - 2 h with constant agitation followed by centrifugation in a Beckman 146 
Type19 rotor at 53,000 ×g, 50 min, 4oC.  The pellet fraction was solubilized in virus 147 
storage buffer (VSB) (50 mM Tris-HCl, pH 7.8) and layered onto a 10 - 40% (w/v) linear 148 
sucrose density gradient made up in VSB, centrifuged in a Beckman SW28 rotor for 20 149 
min at 72,000 ×g at 4oC.  The virus band was identified by light scattering, removed from 150 
the gradient and concentrated by centrifugation.  Resuspended virus was incubated with 151 
50 µg/ml proteinase K in VSB for 4 h at 25oC to disassociate and degrade contaminating 152 
proteins (this treatment has no effect on virus infectivity).  The proteinase K treated virus 153 
was layered onto a 20 - 40% linear iodixanol (OptiPrep™, Axis-Shield, Oslo, Norway) 154 
gradient in VSB and centrifuged at 72,000 ×g in a Beckman SW28 rotor for 4 h at 25oC 155 
for isopynic separation.  The gradient produced a single major light-scattering band at 156 
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~32% iodixanol corresponding to a density of 1.171 g/ml.  The virus band was removed 157 
by side-puncture of the centrifugation tube, diluted approximately 10 fold with VSB, then 158 
concentrated by centrifugation in a Beckman Ti50.2 rotor at 80,000 ×g for 3 h at 4oC.  159 
The pellet fraction was re-suspended in VSB, then filter sterilized with a 0.45 µm cutoff 160 
membrane, and stored at 4oC.  The virus was quantified by UV/visible scanning 161 
spectroscopy using an extinction coefficient of A260/0.1% = 10.7 (52) and plaque assayed to 162 
determine the number of infectious particles.  These preparations typically yielded 163 
several milliliters of stock virus at 1 - 10 x 1011 pfu/ml.  The infectious to total particle 164 
ratio is normally 0.25 - 0.5 for such preparations (53).   165 
These preparations were used both for re-sequencing the PBCV-1 genome and the 166 
determination of the proteome; the proteome was determined by two independent 167 
methods using mass spectrometry of trypsin digested proteins. 168 
Re-sequencing and annotation of the PBCV-1 genome.  Preliminary proteomic 169 
analyzes using the existing PBCV-1 gene annotations (NCBI Refseq: NC_000852) 170 
revealed possible errors in the genome sequence, which prompted us to re-sequence the 171 
PBCV-1 genome.  PBCV-1 DNA was purified from virions treated with DNase I, 172 
sequenced using Roche 454 Life Sciences GS FLX Titanium chemistry, and assembled 173 
as described in the Supplemental Information section (SI).  PBCV-1 contigs were 174 
identified and annotated as described in the SI. 175 
Proteomics method 1. SDS-PAGE/Trypsin/HPLC/Ion Spray/MS-MS. 176 
Particle disruption and protein extraction.  The PBCV-1 virion proteome was 177 
evaluated with two independent methodologies, see Figure 1. In the first method virion 178 
proteins were solubilized essentially as described (25) with reduction of the proteins by 179 
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adjusting 50 µg of virions in 50 µl.  An equal volume of cracking buffer [50 mM Tris pH 180 
8.5, 5 mM of the reducing agent dithiothreitol (freshly reduced with tributylphosphine; in 181 
some experiments beta-mercaptoethanol was substituted for dithiothreitol), 1% SDS, 182 
0.1% crystal violet and 1% Ficoll 400] was added.  The sample was heated to 100oC for 3 183 
min.  The reduced proteins were subsequently alkylated by adjusting the solution to 12.5 184 
mM iodoacetamide with a 0.25 M stock, then heating to 100oC for 1 min.  These samples 185 
were immediately subjected to SDS-PAGE.  Alternatively, the proteins were alkylated 186 
without previous reduction by the same procedure. 187 
Alternatively, phenolic extractions were used to isolate virion proteins.  Reduced 188 
and alkylated proteins were adjusted to 40% sucrose to increase the density of the 189 
solution.  These preparations were then extracted with an equal volume of water-190 
saturated phenol or water-saturated phenol with toluene added to increase the 191 
hydrophobicity of the phenol.  The protein-containing phenolic phase was removed, and 192 
protein was precipitated with 10 volumes of methanol then dissolved and heated in 193 
cracking buffer. 194 
One-dimensional SDS-PAGE.  Proteins were separated on thirty-two cm linear 195 
gradient (4-20%) polyacrylamide gels with 0.1% SDS and 375 mM Tris, pH 8.7 tank 196 
buffer of 25 mM Tris/190 mM glycine.  The samples were electrophoresed at room 197 
temperature till the crystal violet tracking dye reached the bottom of the gel. 198 
The gel was fixed and stained with Sypro-Ruby according to the manufacturer’s 199 
recommendation (Life Technologies Corporation).  The stained gel was imaged using a 200 
blue box transluminator.  Once imaged, the gel was cut into 32 one cm size pieces being 201 
careful to clean the scalpel between samples.  These gel pieces were then processed for 202 
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trypsin-digestion and mass spectrometry analyses.  203 
MS-based microsequencing.  Excised gel pieces were digested for peptide 204 
sequencing using a slightly modified version of a method described by (40).  Briefly, the 205 
samples were washed with 100 mM ammonium bicarbonate, reduced with 10 mM DTT, 206 
alkylated with 55 mM iodoacetamide, washed twice with 100 mM ammonium 207 
bicarbonate, and digested in situ with 10 ng/µl trypsin.  Peptides were extracted with two 208 
60 µl aliquots of 1:1 acetonitrile:water containing 1% formic acid.  The extracts were 209 
reduced in volume to approximately 25 µl using a vacuum centrifugation.   210 
Ten μl of the extract solution was injected onto a trapping column (300 µm x 1 211 
mm) in line with a 75 µm x 15 cm C18 reversed phase LC column (LC- Packings).  212 
Peptides were eluted from the column using a water + 0.1% formic acid (A)/95% 213 
acetonitrile:5% water + 0.1% formic acid (B) gradient with a flow rate of 270 µl/min.  214 
The gradient was developed with the following time profile: 0 min 5% B, 5 min 5% B, 35 215 
min 35% B, 40 min 45% B, 42 min 60% B, 45 min 90% B, 48 min 90% B, 50 min 5% B. 216 
The eluting peptides were analyzed using a Q-TOF Ultima tandem mass 217 
spectrometer (Micromass/Waters, Milford, MA) with electrospray ionization.  Analyses 218 
were performed using data-dependent acquisition (DDA) with the following parameters: 219 
1 sec survey scan (380-1900 Da) followed by up to three 2.4 sec MS/MS acquisitions 220 
(60-1900 Da).  The instrument was operated at a mass resolution of 8,000.  The 221 
instrument was calibrated using fragment ion masses of doubly protonated Glu-222 
fibrinopeptide. 223 
Mass ion analyses.  The MS/MS data were processed using Masslynx software 224 
(Micromass) to produce peak lists for database searching.  MASCOT (Matrix Science, 225 
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Boston, MA) was used as the search engine.  Data were searched against the NCBI non-226 
redundant database.  The following search parameters were used: mass accuracy 0.1 Da, 227 
enzyme specificity trypsin, fixed modification CAM, variable modification oxidized 228 
methionine.  Protein identifications were based on random probability scores with a 229 
minimum value of 25.  Although this number varied from experiment to experiment, 230 
typically it was 25 or less for p < 0.05 confidence.   231 
Relative abundances.  Approximate, relative quantitation of the proteins was 232 
determined using the exponentially modified protein abundance index (emPAI) (18).  233 
This method uses the number of observed peptides compared to the number of observable 234 
peptides giving a ratio that is directly proportional to relative abundance of the protein in 235 
the mixture when adjusted exponentially (emPAI= 10PAI-1; where PAI = number of 236 
observed peptides per protein/number of observable peptides per protein).  237 
Proteomics method 2. PPS/Trypsin/HPLC/MS-MS 238 
Protein extraction and trypsin digest.  One hundred µg of PBCV-1 was mixed 239 
1:1 with 100 mM ammonium bicarbonate buffer pH 8.3 containing 0.2% PPS (Protein 240 
Discovery Labs, San Diego, CA) [final concentration 50 mM ammonium bicarbonate, 241 
0.1% PPS], boiled for 5 min, cooled to room temperature, reduced and alkylated with 5 242 
mM dithiothreitol and 15 mM iodoacetamide, then digested with sequencing grade 243 
trypsin at a 1:50 trypsin:protein ratio, for 4 h at 37oC, with shaking.  The digested 244 
samples were acidified with HCl (200 mM), incubated at 37oC, and centrifuged at 4oC, to 245 
remove PPS prior to LC-MS application.  246 
LC Methods.  Buffer solutions were made with LC-MS grade water, acetonitrile, 247 
and formic acid and consisted of 5% acetonitrile/0.1% formic acid in water (Buffer A) 248 
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and 100% acetonitrile/0.1% formic acid (Buffer B).  Two or 4 µg total protein from each 249 
sample was loaded onto a reverse phase (RP) trap (5 μm, 200 Å, Magic; Michrom 250 
Bioresources, Auburn, CA) with 100% buffer A and washed for 10 min prior to 251 
separation on a microcapillary column.  The microcapillary column was constructed by 252 
slurry packing 18 cm of C18 material (2.7 µm, 100 Å, HALO, Michrom Bioresources) 253 
into a 75 µm ID fused silica capillary, which was previously pulled to a tip diameter of 5 254 
µm using a Sutter Instruments laser puller (Sutter Manufacturing, Novato, CA).  255 
Separations were performed on an Eksigent 1D+ nano-LC (Eksigent, Dublin, CA) LCQ-256 
Deca XP Plus: 0-30% B over 240 min, 30-70% B over 10 min at 300µl/min; LTQ-Velos: 257 
0-30% B over 80 min, 35-70% B over 10 minutes at 300µl/min.  258 
Mass Spectrometry Methods.  Data-dependent tandem mass spectrometry 259 
(MS/MS) analysis was performed using an LTQ-Velos or LCQ Deca XP Plus mass 260 
spectrometer (ThermoFisher, San Jose, CA).  Full MS spectra were acquired in centroid 261 
mode, with a mass range of 400–2000 Da.  To prevent repetitive analysis, dynamic 262 
exclusion was enabled with a LTQ-Velos: repeat count of 1, a repeat duration of 30 sec, 263 
an exclusion list size of 500, and an exclusion-duration of 90 sec.  Tandem mass spectra 264 
were collected using a normalized collision energy of 35% and an isolation window of 3 265 
Da.  266 
For the LTQ one full scan was followed by 6 MS-MS scans of the 6 most intense 267 
precursor ions not on the dynamic exclusion list.  LCQ-Deca XP Plus: repeat count of 1, 268 
a repeat duration of 30 sec, an exclusion list size of 100, and an exclusion-duration of 20 269 
sec.  Tandem mass spectra were collected using a normalized collision energy of 35% 270 
and an isolation window of 4 Da.   271 
Page 13 of 47 
 
For the LCQ one full scan was followed by 3 MS-MS scans of the 3 most intense 272 
precursor ions not on the dynamic exclusion list. 273 
Mass ion analyses.  Processing and searching of MS/MS spectra and analyzing 274 
peptide and protein identification data were performed using SPIRE (Systematic Protein 275 
Investigative Research Environment, www.proteinspire.org) system with default 276 
parameters.  Searches were conducted using the X!Tandem search engine (9) within a 277 
2.5-Da mass error, a variable modification for methionine oxidation (16@M), and a fixed 278 
modification for iodoacetamide (57@C) along with the default search parameters.  The 279 
sequence file for the searches of the modules contained PBCV-1 appended to a decoy 280 
database of Ostreococcus tauri.  In addition, a randomly reshuffled version of each 281 
database was appended for error estimation.  The search results were processed with the 282 
LIPS (logistic identification of peptide sequences) model (16) to generate peptide spectra 283 
scores.  Peptide identification probabilities and FDRs were calculated based on the 284 
reshuffled matches using an isotonic regression model (17).  A 90% certainty was used as 285 
the basis for spectra identifications.  A recently introduced approach was used to estimate 286 
the protein identification FDR from individual peptide identification probabilities (17). 287 
RESULTS AND DISCUSSION 288 
Re-sequenced and re-annotated PBCV-1 genome.  The original sequence and 289 
annotation of PBCV-1 was completed over 15 years ago using primitive procedures when 290 
compared to current technology.  During the past 15 years we have corrected the 291 
sequence of individual genes as mistakes were detected.  Those mistakes and preliminary 292 
results from the current proteomic analyses that indicated sequencing errors, prompted us 293 
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to re-sequence PBCV-1.  The revised PBCV-1 genome contains 330,805 nucleotide pairs 294 
compared to 330,743 nucleotide pairs from the earlier sequencing effort.  The two 295 
genome versions differed by 458 indel positions (mostly single nucleotide indels) and 296 
188 substitutions.  This genome sequence and annotation are deposited at the National 297 
Center for Biotechnology Information (NCBI) as reference sequence NC_000852.5; the 298 
genome annotation is listed in SI Table S1.  The re-sequenced genome submitted to 299 
NCBI includes the 2,222 base pair terminal inverted repeat ends, but not the incompletely 300 
base-paired covalently closed hairpin 35-nucleotide loops at each end of the genome. 301 
Thus, the genome is a linear double-stranded DNA of 330,805 base pairs with two 35-302 
nucleotide partially paired terminal loops. Sequencing reads were obtained through the 303 
hairpin loops (data not shown). When compared to the published results from Zhang et al. 304 
(1994), the terminal repeats and hairpin loops are identical. Nucleotide 1 refers to the first 305 
paired nucleotide following the hairpin loop. 306 
One significant change in the new annotation is that ORFs of 40 codons or more 307 
were classified as potential CDSs; the previous annotation used 65 codons as the 308 
minimum size.  This resulted in 802 ORFs, of which 416 ORFs were classified as 309 
“major” CDSs (designated with an upper case “A”) based on the following supporting 310 
evidence: these ORFs did not have larger overlapping ORFs and/or were expressed 311 
transcriptionally (65) and/or the protein was identified in the proteomic analyses.  The 312 
major ORFs cover 92.8% of the genome sequence and have an average protein product 313 
size of 249 amino acids.  In addition, 11 tRNA genes were identified as reported 314 
previously.  The remaining 386 ORFs were labeled “minor” ORFs (designated with a 315 
lower case “a”) and most of them are probably not CDSs.  They encode putative proteins 316 
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with an average size of 86 amino acids.  The gene annotations, along with functional 317 
assignments, are listed in SI Table S1. 318 
 319 
To avoid confusion in the literature, we kept the same gene numbering system as 320 
used previously, i.e., a gene labeled as a250r is still labeled a250r.  When two adjacent 321 
ORFs were found to be a single ORF, e.g., A189R and A192R, we named it A189/192R.  322 
Finally, where smaller ORFs were identified that were not considered previously, we 323 
labeled them with a lower case letter, e.g., A254aR.  These new gene annotations were 324 
used for the proteomic analyses of the virion proteins. 325 
PBCV-1 virion proteome.  Highly purified virions were used for the proteome 326 
analyses, including a "protease treatment” step where the particles were incubated with 327 
proteinase K to degrade proteins non-specifically associated with the particle surface.  328 
Proteinase K treatment does not affect PBCV-1 infectivity (3).  Using a combination of 329 
sample treatment, separation and mass spectrometry methods, 148 virus-encoded proteins 330 
were detected in the PBCV-1 virion (Fig. 2B).  For abundant proteins, any method was 331 
sufficient to detect mass ions allowing identification with high confidence.  However, 332 
some of the low abundance and small proteins were only identified by one of the two 333 
methods, primarily due to differential separation where the protein of interest was 334 
separated from an abundant, and consequently masking, protein.  The dynamic range of 335 
these analyses was ~104 with the MCP present at approximately 103 copies per virion 336 
relative to a hypothetical protein present at one copy per virion.  Thus, the sample 337 
treatment and separation method selected were important elements in the proteome 338 
determination.  The proteins were identified by two independent methods, 62% of the 339 
proteins were detected by both methods.  Twenty six percent were uniquely identified 340 
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with the SDS-PAGE method (Method 1) and 11% were uniquely identified with the PPS 341 
solubilization method (Method 2).  It is important to note some proteins are not readily 342 
detected using mass spectrometric methods, e. g., small proteins associated with 343 
membranes (39).  Thus, the proteome reported here may increase with additional data in 344 
the future.  However, the results presented are the compilation of many experiments 345 
using varying conditions for protein extraction and isolation giving us high confidence in 346 
the compiled list of proteins including several proteins with predicted transmembrane 347 
domains, as well as many small proteins; i. e., less than 10 kDa (Table 1). 348 
Method 1. SDS-PAGE/Trypsin/HPLC/Ion Spray/MS-MS.  Method 1 349 
identified 137 virus-encoded proteins in the virion.  Virion proteins were either: i) 350 
extracted directly into gel sample buffer, ii) first extracted into a phenolic phase to 351 
remove nucleic acids, or iii) extracted into a hypo-polarized phenolic phase supplemented 352 
with toluene to further extract highly polar proteins such as glycosylated proteins.  The 353 
extracted proteins were either alkylated with iodoacetamide and then reduced, or left 354 
alkylated.  While these methods helped extract certain proteins, others were excluded and 355 
no additional proteins were detected beyond the standard method of extracting into the 356 
gel sample buffer. 357 
Protein separation using one-dimensional gel electrophoresis resolved ~30 distinct 358 
SYPRO-Ruby stained bands.  The dynamic range of observed polypeptides is large.  For 359 
example, the MCP migrates at approximately 54 kDa and is the most abundant protein in 360 
the virion, migrating near the mid-point of the gel (Fig. 2A, gel position 13).  The MCP 361 
has a nominal mass of 48 kDa and is post-translationally modified with sugars at 6 362 
positions (31) and with at least one myristyl group (36), as well as having the amino 363 
Page 17 of 47 
 
terminal methionine removed (13).  This very abundant protein contrasts to proteins 364 
detected in regions of the gel where little or no staining was observed, e. g., gel positions 365 
#1, 8, 9, 31, 32 in Fig. 2A.  Although very little staining was observed in these regions, 366 
several proteins were detected by the mass spectrometry analyses.  Indeed, proteins were 367 
detected in all regions of the gel.   368 
Qualitative changes in protein mobility were observed with different sample 369 
treatments (SI Fig. S1).  Samples that were alkylated with iodoacetamide, gave nearly the 370 
same number of bands as those that were reduced with dithiothreitol (or beta-371 
mercaptoethanol) and alkylated.  However, the mobility of a few proteins was altered by 372 
this differential treatment, as visualized by SYPRO-Ruby staining.  For example, a 373 
protein band(s) migrating at gel position #5 in the alkylated sample is absent in the 374 
sample that was both reduced and alkylated.  Conversely, proteins observed at gel 375 
positions 7 and 8 for the reduced and alkylated sample are not visible in samples only 376 
alkylated.  Several other differentials occurred between these two treatments; 377 
nevertheless, the protein profiles determined for these treatments were similar for the 378 
prominent proteins.  The use of multiple treatment and separation methods was most 379 
useful for low abundant polypeptides as indicated by MASCOT score.  380 
Method 2. Trypsin/HPLC/MS-MS.  The trypsin/HPLC/MS-MS method 381 
identified 126 virus-encoded proteins, 16 of which were unique to this method.  All 382 
tryptic or semi-tryptic peptide matches were analyzed using the SPIRE analysis suite (14-383 
17) against PBCV-1 and C. variabilis genome databases.  Restricting the matches to 384 
tryptic only peptides did not decrease the false positive rate, so full semi-tryptic searching 385 
was employed.  The false positive rate was estimated from searches of a decoy database 386 
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of the Ostreococcus tauri proteome.  The false positive rate was computed to be 0.42%, 387 
so one of the 126 proteins identified in this group of experiments might be a false 388 
positive.  All the proteins identified had a confidence level of 'high' or 'very high' in at 389 
least one of the ten analyses in this group and were considered to be in the virion. 390 
Of the ten analyses performed with this method, 6 proteins were detected in only 391 
one analysis.  One of the proteins was found in 2 analyses, one in 3 analyses, 4 in four 392 
analyses, 21 in 5 analyses, 2 in 6 analyses, 2 in 9 analyses, and 89 in all 10 analyses.  The 393 
number of analyses in which a protein is observed, can be influenced by either variability 394 
inherent in mass spectrometry based proteomics experiments, variability in expression, 395 
stability of the proteins or false positive results. 396 
Proteome is lower (L) strand and right hand side (R) biased.  The genes 397 
predicted to encode proteins in the PBCV-1 genome are biased to the right side (262 of 398 
416) relative to the mid-point of the genome; this is also reflected in the number of gene 399 
products in the proteome (81 CDSs from right side, 67 CDSs from left side) (Fig. 3).  In 400 
addition, there is a bias to the reverse strand (L) for the right half of the genome in both 401 
the total predicted proteins (159 of the 416, Fig. 3A) and the virion proteome (48 of 148, 402 
Fig. 3B).  This bias is consistent with certain viable PBCV-1 spontaneous large deletion 403 
mutants where up to 40 kbp of the left side of the genome can be deleted (24, 54), and 404 
these are recapitulated in the chlorovirus CVK2 (6).  The right side L strand virion-405 
coding genes have a mean G+C content of 22%; whereas, the overall G+C content of the 406 
genome is 40% and mean G+C content of all the coding genes is 31%.  These 407 
observations suggest the left side of the genome has less selection pressure relative to the 408 
right side for the essential functions of virion assembly and maturation, The right side L 409 
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strand is relatively dense with virion-associated genes (38% of the total) with atypical 410 
nucleotide composition; whereas, the corresponding left side of the genome is relatively 411 
sparse (14%) with regards to virion proteins. 412 
Proteome is skewed to small basic proteins.  The PBCV-1 proteome has 413 
proteins ranging in molecular weights from 4.9 to 143 kDa and in isoelectric points from 414 
3.6 to 13.0, assuming no post-translational modifications (Fig. 4).  Quantitatively, the 415 
proteome is dominated by the MCP, centrally located in these distributions.  416 
Qualitatively, the proteome is skewed to basic (~75%) and relatively small proteins, 417 
approximately 50% are less than 20 kDa, and 63% of the proteins have molecular 418 
weights less than 50 kDa and pI values greater than 7.0.  This skewing to the more basic 419 
side is interesting because the electrostatic charge of the 6 x 105 phosphate moieties in the 420 
virus genome are probably neutralized by basic proteins (59).  However, this prediction 421 
must be evaluated further because the stoichiometry of the virion proteins is uncertain.  422 
Additionally, how these relate to the chlorovirus CVK2 proteins with DNA binding and 423 
protein kinase activities needs to be clarified (60). 424 
Two-dimensional gel analyses using isoelectric focusing versus mass separations 425 
support the skewing to basic and small proteins, suggesting that the majority of these 426 
proteins are not post-translationally modified in such a way that causes significant 427 
deviations of the predicted charge-mass migration (results not shown).  However, we 428 
never obtained good resolution of the proteins using 2-D gels, even though many 429 
protocols were tried, because the MCP dominated the gel. 430 
Membrane proteins.  The virion proteins were evaluated for potential 431 
transmembrane domains with three independent methods (20, 30, 50); these results 432 
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suggest that at least 26% of the proteome may be associated with a membrane structure 433 
(Table 1), presumably the internal membrane of the virion.  Two-thirds of the CDSs with 434 
predicted transmembrane domains (3 out of 3 programs used) were detected by both 435 
proteomic methods.  The remaining 1/3 of the CDSs were detected equally with Method 436 
1 biased to somewhat larger (mean MW = 23.8 kDa) and more basic proteins (mean pI = 437 
9.2), whereas Method 2 was biased to smaller (mean MW = 10.3 kDa) and less basic 438 
proteins (mean pI = 7.8). 439 
The origin of the PBCV-1 internal membrane is unknown.  If all, or at least most, 440 
of the PBCV-1 internal membrane contains virus-encoded proteins and no host-encoded 441 
proteins, it would suggest extensive modification of the host membrane to form the virus 442 
membrane. 443 
PBCV-basic adaptor domain containing proteins.  Eight PBCV-1 CDSs have 444 
at least one copy of a small, highly positively charged C-terminal domain, referred to as 445 
the PBCV-basic adaptor domain (19): A092/093L, A176L, A205R, A278L, A282L, 446 
A436L, A571R and A676R.  All of these CDS were detected in the virion (Table 1).  447 
These proteins range in size from 6.9 - 69 kDa, but their pI values are very basic, 10.6 - 448 
13.0.  Five of these proteins contain a single copy of the basic adaptor domain; however 449 
A092/093L and A278L have 2 copies, and A282L has 3 copies.  A278L and A282L are 450 
S/T protein kinases (51).  The A676R protein contains both the PBCV-basic adaptor 451 
domain and a 2-cysteine domain (Pfam 08793), which is a virus-specific domain fused to 452 
OUT/A20-like peptidases and S/T protein kinases and is suggested to function as a 453 
targeting device for specific substrates (19).  The PBCV-basic adaptor domain is only 454 
found in the chloroviruses, and A176L is only found in PBCV-1.  The function of the 455 
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PBCV-basic adaptor domain is unknown. 456 
MCP paralogs.  The initial understanding of the architectural makeup of the 457 
PBCV-1 virion was a simple quasi-icosahedral particle consisting of a single MCP 458 
(Vp54) (64).  This picture has evolved to the present 8.5 Å resolution complex particle 459 
with several surface features, including a unique vertex with a spike structure and fiber-460 
like structures associated with some capsomers in the trisymmetrons (5, 66).  Genome 461 
sequencing revealed genes encoding 6 additional capsid-like proteins (26).  Previously 462 
these paralogs were not considered relevant because at least two of them (genes a010r 463 
and a011l) could be deleted from the genome without loss of virion formation (24).  464 
However, the proteome presented here indicates that all of the capsid-like proteins are 465 
present in the virion (Table 1) and they fall into 5 paralog classes (Fig. 5A).  Each of 466 
these proteins contain 2 conserved domains [D1 (green) and D2 (red)] (Fig. 5B) 467 
consistent with the Vp54 structure (Fig. 5C).  The relative abundance of the proteins, as 468 
estimated by their emPAI value, ranged from 1 (A384dL and A383R) to 13 (A430L and 469 
A011L).  These abundance ratios support the hypothesis that the architecture of the 470 
PBCV-1 virion is composed of a complex mixture of capsids and that the capsomers are 471 
composed of heteromeric proteins with a conserved structure.  Additionally, the 2 minor 472 
capsid-like proteins, A383R and A384dL, contain an additional domain that is similar to 473 
the chitin binding peritrophin-A domain (Pfam 01607.17) (SI Table S1) and may 474 
contribute to the attachment of the virion to the algal cell surface.  The relative abundance 475 
of these proteins is consistent with the frequency of fiber structures found in each 476 
trisymmetron, but the composition of these structures is unknown.  477 
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The estimated relative abundances of virion proteins were determined using the 478 
emPAI method (18) for the Method 1 data set.  The distribution of the capsid proteins 479 
suggests a more complex assembly of PBCV-1 capsids than was previously assumed for 480 
a single MCP (Vp54) responsible for the particle architecture.  We assume the MCP 481 
(A430L) is present in 1440 copies per virion for these calculations and other protein 482 
abundances were estimated from this value (Fig. 5B).  The data indicate there are two 483 
capsid proteins of relatively high abundance (A430L and A011L), two capsid proteins 484 
were present at approximately one-half the abundance of these (A010R and A558L), one 485 
capsid protein present at one-third abundance (A622L), and two capsid proteins were 486 
present in relatively low abundance (A383R and A384dL).  Assuming these ratios, 487 
icosahedral symmetry, and the fact that the virion is composed of 1680 capsids (64), each 488 
of the triangular facets of the icosahedron would contain seven proteins in ratios of 489 
72:72:36:36:24:1:1.  Recent structural analysis of PBCV-1 at 8.5 Å resolution indicates 490 
the capsomer volumes are more varied than previously thought (66), but how these 491 
capsids are arranged is not known.  The trimeric capsomers may be homomeric (as 492 
previously thought), or possibly heteromeric utilizing the conserved beta-barrel domains 493 
as binding surfaces.  This higher complexity of virion structure is consistent with several 494 
other large DNA viruses where multiple capsid proteins have been detected; herpes 495 
viruses have 4 to 7 capsid proteins (22, 33) and mimivirus has at least 5 capsid proteins 496 
(37).  The emPAI method was used to estimate  abundances of  intracellular mature 497 
virion proteins of vaccinia virus (7) indicating a dynamic range of 1 to 1000 with certain 498 
core proteins being most abundant (i. e., A4L, A10L, F17R and A3L), as well as one with 499 
low abundance (i. e., E11L).  500 
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PBCV-1 proteome functionalities.  The 148 virion proteins were grouped into 501 
11 functional/structural categories (SI Fig. S3A) and compared to the distribution of 502 
CDSs of the overall genome (SI Fig. S3B).  The majority (72%) of virion proteins are in 503 
the unknown function category.  However, several functions are inferred by sequence 504 
similarity analyses and 13 of the 148 proteins have demonstrated functions that include 505 
DNA binding, cell signaling via phosphorylation, DNA degradation, virus structure, cell 506 
attachment, and polyamine biosynthesis such as homospermidine synthase.  Among the 507 
identified CDSs are the restriction endonucleases R.CviAII (A252R) and R.CviAI 508 
(A579L) thought to be responsible for host DNA degradation early in the infection cycle 509 
(3).  510 
Virion morphogenesis is one of the last events in the PBCV-1 replication cycle 511 
and it is reasonable that virion proteins are synthesized during the late phase.  Most of the 512 
proteome (87%) is from genes expressed either late or early-late (65); however, the time 513 
of expression has not been determined for 23 new CDSs discovered with the resequence 514 
and annotation (SI Fig. S2).  Eleven proteins are from genes transcribed in the early 515 
phase of replication: 7 of these proteins were detected by a single proteomic method with 516 
a relatively low number of unique peptides detected.  Therefore, these 7 proteins require 517 
further verification.  Three of these early proteins, A171R, A440L and A443R have 518 
unknown functions.  The A456L protein has two conserved domains, a D5 N superfamily 519 
domain found in certain viral DNA primases (PfamA: PF08706.4) and a phage/plasmid 520 
primase P4 family C-terminal domain with predicted ATPase activity.  The A548L 521 
protein has two conserved P-loop NTPase domains that are associated with DEXDc-, 522 
DEAD- and DEAH-box proteins, including the hepatitis C virus NS3 helicases (PfamA: 523 
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PF00176.16).  Thus, these proteins might contribute to early transcriptional events that 524 
occur within minutes of infection.   525 
PBCV-1 packaged host protein.  The PBCV-1 proteome contains one protein 526 
(101 amino acids) derived from the host (GenBank: EFN53917.1; 4); the protein was 527 
detected by both proteomic methods.  This protein is most similar to a fungal 93 amino 528 
acid Naumovozyma dairenensis CBS 421 nucleosome binding protein (NCBI reference 529 
sequence: XP_003667927.1) and similar to the HMGB-UBF_HMG-box, class II and III 530 
members of the HMG-box superfamily of DNA-binding proteins.  It has no similarity to 531 
any PBCV-1 encoded protein.  HMG-box containing proteins bind non-B-type DNA 532 
conformations with high affinity (45) and they are involved in regulation of DNA-533 
dependent processes such as transcription, replication and DNA repair, all of which 534 
require changing the conformation of chromatin (49).  Thus, this host protein may be 535 
important in initiating PBCV-1 gene expression, which occurs within minutes of 536 
infection (65).  At least two other large DNA viruses contain chromosomal proteins in the 537 
virion.  An HMG-box protein (HMG1) and a histone H2B.q protein occur in the Western 538 
Reserve strain of vaccinia virus (38) and murine cytomegalovirus virions have a histone 539 
H2A protein (22), suggesting large DNA viruses utilize host-derived proteins for DNA 540 
binding functions.  541 
Presumed virion proteins that were not detected.  A few proteins were 542 
expected to be packaged in PBCV-1 that were absent in the proteome analysis.  As noted 543 
previously, PBCV-1 packages one or more enzymes  involved in digesting the host cell 544 
wall during infection (29).  Annotation of the PBCV-1 genome identified 5 enzymes that 545 
might be involved in this process - two chitinases, a chitosanase, a β 1-3 glucanase and a 546 
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β & α 1,4 glucuoronic lyase (SI Table S1).  Recombinant proteins indicated that all of 547 
these enzymes are functional (46, 47) and western blots suggested that one of the 548 
chitinases and the chitosanase were in the virion (47).  However, none of these five 549 
proteins were detected in the proteome analysis.  Consequently, the enzyme(s) involved 550 
in digesting the host cell wall is unknown. 551 
Circumstantial evidence suggests that PBCV-1 and other chloroviruses package a 552 
small virus-encoded K+ channel protein, named Kcv (12).  It has been hypothesized that 553 
Kcv is involved in depolarizing the host membrane, which occurs immediately after virus 554 
infection.  However, Kcv was not detected in this proteome study.  On the other hand, at 555 
least one putative protein (A201L) with predicted physical/chemical transmembrane 556 
properties similar to Kcv was detected in the PBCV-1 virion with proteomic method 1.  557 
Thus, this methodology can detect small proteins with transmembrane domains, as in 558 
Kcv. 559 
CONCLUSIONS 560 
Re-sequencing and annotation of the 331 kbp chlorovirus PBCV-1 genome 561 
revealed that the virus encodes 416 predicted CDSs, using a minimum ORF size of 40 562 
codons, and 11 tRNAs.  Proteome analysis of highly purified PBCV-1 virions identified 563 
148 virus-encoded proteins (about 35% of the coding capacity of the virus) and one host 564 
protein.  Some of these proteins appear to be structural/architectural, whereas others have 565 
enzymatic, chromatin modification and signal transduction functions.  However, 106 of 566 
these proteins have no known function or homologs in the existing gene databases except 567 
as orthologs with other chloroviruses, phycodnaviruses and NCLDVs.  The genes 568 
encoding these proteins are dispersed throughout the virus genome and 84% are 569 
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transcribed late or early-late in the infection cycle, which is consistent with virion 570 
morphogenesis.   571 
Probably the biggest surprise is that so many virus-encoded proteins were 572 
detected in the virion and only one host encoded protein.  However, except for the MCP 573 
Vp54, we cannot definitively assign a protein(s) to any of the other structural features of 574 
the virus, including the additional 6 major capsid-like proteins, the long spike structure, 575 
the surface fibers on the trisymmetrons, or the long glue protein homologs of PRD1 and 576 
the membrane protein dimer located at the edge of the trisymmetrons and internal 577 
membrane (66).  These await further structural analyses.  Obviously one question is: Are 578 
all of these virion-associated proteins essential for creating an infectious virus or are 579 
some of them the result of 'sloppy packaging', i. e., fortuitously associated with the 580 
particle.  This is a difficult question to answer - but it is clear that PBCV-1 581 
morphogenesis is selective in terms of what it incorporates; e.g., the virus packages 2 582 
virus-encoded restriction endonucleases, but not their corresponding DNA 583 
methyltransferases.  In addition, only one host protein was detected in the virion; no host 584 
membrane proteins were detected.  585 
The PBCV-1 capsid protein composition may be somewhat flexible because the 586 
genes encoding 2 of the capsid proteins (A010R and A011L) can be deleted (6, 24), yet 587 
these deletion mutants are viable.  This finding suggests some type of compensation in 588 
capsid protein utility.  Among large DNA viruses, the number of capsid proteins ranges 589 
from 4 to 7 and these homologs are virion-associated (e. g., 22, 33, 37), thus the 590 
discovery of 7 putative capsid proteins in the PBCV-1 virion is consistent with this theme 591 
yet little is known how these proteins contribute to virion structure or function.   592 
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These data are essential for understanding the immediate-early events of infection 593 
such as binding, entrisome, macromolecular synthetic shutoff, DNA degradation, viral 594 
transcription, etc. (48).  PBCV-1 is emblematic of the giant viruses in that they are large, 595 
complex, and highly diverse (11).  When characterizing these viruses, the traditional 596 
meaning of the term “structural protein” (i. e., virion-associated) has lost its meaning.  597 
Giant virus virions incorporate both structural/architectural proteins as well as many 598 
other proteins with a wide range of functionalities likely directed at the immediate-early 599 
events of infection before viral transcription de novo is initiated.  Why giant viruses have 600 
so many genes continues to intrigue virologists, but as more giant viruses are discovered 601 
there will be more opportunities to explore this question. 602 
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Figure legends 812 
Figure 1. Proteomic methodologies for PBCV-1 virions.  813 
Figure 2. SDS-PAGE protein separation and virion proteome mapped onto the PBCV-1 814 
genome.  The PBCV-1 genome was re-sequenced, assembled and annotated to correct 815 
existing sequence errors.  The 416 predicted CDSs are represented as grey arrows 816 
running both clockwise and counter-clockwise along the genome (panel B).  Note: the 817 
diagram is circular, but there is a break at the 12 o’clock position because the viral 818 
genome is a linear molecule with terminal inverted repeats and closed hairpin ends. The 819 
terminal sequences (inverted repeats and hairpin ends) were found to be identical to those 820 
reported previously (68).  The polycistronic gene encoding 11 tRNAs is presented in red 821 
(see 6 o’clock).  The 148 proteins of the virion proteome were determined using two 822 
independent mass spectrometry-based methods (see Materials and Methods).  The results 823 
of each method are shown, proteins determined uniquely by method 1 are presented in 824 
magenta, proteins determined uniquely by method 2 are presented in blue, proteins 825 
determined by both methods 1 and 2 are presented in brown.  The map was developed 826 
from the CGView software (44).  Panel A shows the distribution of virion proteins with 827 
SDS polyacrylamide gel separation.  The numbers to the left indicate the gel fragment 828 
that was analyzed.  829 
Figure 3.  Expression stage distribution of PBCV-1 CDSs, a quartile analysis.  The 830 
number of all coding CDSs (panel A) expressed either during the early (blue), early-late 831 
(red), late (green), or not determined (nd, purple) is shown as a function of the genome 832 
map position.  The genome map is divided into four regions, both the direct (“R” genes) 833 
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and reverse (“L” genes) on each half of the genome (left half gene numbers: 001 – 327; 834 
right half gene numbers: 328 – 692).  Panel B shows the distribution of virion-associated 835 
CDSs with respect to expression stage and genome position.  836 
Figure 4.  Mass versus pI distribution of PBCV-1 virion CDSs identified by two 837 
independent proteomic methods.  The virion proteins are displayed as a function of their 838 
intrinsic molecular weight and isoelectric point.  The results of each method are shown, 839 
proteins determined uniquely using method 1 are presented in magenta, proteins 840 
determined uniquely using method 2 are presented in blue, proteins determined using 841 
both methods 1 and 2 are presented in brown.  Note that Method 2 was especially useful 842 
for discovering a set of low molecular weight proteins that were not detected with 843 
Method 1.   844 
Figure 5.  Capsid protein paralog classes and relative abundances in PBCV-1.  The seven 845 
capsid-like proteins detected in the PBCV-1 virion were evaluated against a dataset of 846 
chloroviruses, including PBCV-1 (RefSeq NC_000852.5), NY-2A (RefSeq 847 
NC_009898.1), AR158 (RefSeq NC_009899.1), MT325 (GenBank DQ491001.1), FR483 848 
(RefSeq NC_008603.1), and ATCV-1 (RefSeq NC_008724.1).  These 7 proteins had 849 
homologs in each of the viruses that separate into 5 distinct paralog classes (I – V) as 850 
shown in the neighbor joining tree (panel A) (see SI Table S3 for CDS accession 851 
numbers).  The sequence for PBCV-1 A384dL, a member of paralog class V which is 852 
distantly related, was used as the out-group to root the phylogenetic analysis using the 853 
website www.phylogeny.fr (10).  Muscle was used to align the sequences.  Bootstrap 854 
analysis was used to construct the tree.  Similar tree topologies were produced by 855 
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maximum likelihood and maximum parsimony analyses.  The values on the branches are 856 
the percentage of bootstrap support (200 replicates).  Only bootstrap values >50% are 857 
shown.  The distance bar represents 0.2 amino acid substitution per site.  Panel B presents 858 
the PBCV-1 capsid proteins grouped into 5 paralog classes within their two conserved 859 
domains.  The D1 domain (green, column A) and the D2 (red, column D) NCLDV 860 
superfamily capsid domain were previously determined by structure analysis of the Vp54 861 
MCP (31) (panel C).  The relative abundances as determined with the emPAI method for 862 
the Method 1 data are listed to the right of the table, as well as the hypothetical estimated 863 
copies per virion of each capsid protein.  Note, the two proteins of relatively lower 864 
abundance contain chitin binding peritrophin-A conserved domains (columns C and E).865 
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Table 1. PBCV-1 virion proteome 866 
Protein 
(CDS) 
Da pI Expression 
stage 
Function or putative function Proteomic 
method 
TM predictiona 
T        H       P 
A010R 44998 5.2 Late Capsid protein; PfamA: PF4451.5 [1.9e-50] 1&2 0 0 0 
A011L 45076 5.4 Late Capsid protein; PfamA: PF4451.5 [2.9e-61] 1&2 0 0 0 
A014R 141382 6.3 Late Unknown protein 1&2 0 0 0 
A018L 137639 4.9 Late Unknown protein; PfamA: PF06598.4 
[Chlorovirus glycoprotein repeat] [1.2e-11] 
1 0 0 0 
A025/027/029L 140095 4.4 Late Unknown protein 1&2 0 0 0 
A034R 35163 10.4 Late Protein kinase; PfamA: PF00069.18 [Protein 
kinase domain] [1.4e-07] 
1&2 0 1 0 
A035L 65606 8.9 Late Unknown protein 1&2 0 1 0 
A041R 44315 10.8 Late Unknown protein 1&2 0 1 0 
A051L 22804 8.6 Late Unknown protein 1&2 1 2 1 
A085R 27812 7.8 Late Prolyl 4-hydroxylase; PfamA: PF03171.13 
[2OG-Fe(II) oxygenase superfamily] [3.5e-
11] 
1&2 1 1 1 
A092/093L 49577 10.7 Early-Late Unknown protein; PfamA: PF08789.3 
[PBCV-specific basic adaptor domain] 
[1.2e-15] 
1&2 0 0 0 
A121R 12486 10.8 Early-Late Unknown protein 1&2 0 0 0 
A122/123cL 4912 10.1 N/A Unknown protein 1 0 0 0 
A122/123R 137880 5.0 Late COG5295 [Autotransporter adhesin] [4e-
12]; PfamA: PF06598.4 [Chlorovirus 
glycoprotein repeat] [3.6e-11] / PF11962.1 
[Domain of unknown function (DUF3476)] 
[8.2e-66] 
1 0 31 0 
A127R 27126 10.1 Late Unknown protein 1&2 0 0 0 
A136R 16367 11.5 N/A Unknown protein 1&2 0 0 0 
A137R 8777 10.9 Early Unknown protein 1 0 0 0 
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A139L 17701 8.4 Late Unknown protein 1&2 2 2 2 
A140/145R 120898 11.0 Early-Late Unknown protein 1&2 0 1 0 
A157L 12328 3.9 Early-Late Unknown protein 2 1 1 1 
A164aR 7094 5.8 N/A Unknown protein 2 1 0 0 
A165aL 19024 10.1 N/A Unknown protein 1&2 0 0 0 
A168R 18317 4.6 Late Unknown protein 1&2 1 1 1 
A171R 42413 10.2 Early Unknown protein 1&2 0 0 0 
A172aL 6053 9.8 N/A Unknown protein 1 1 1 0 
A173L 31933 8.2 Early COG1752 [Predicted esterase of the alpha-
beta hydrolase superfamily] [2e-06]; PfamA: 
PF01734.15 [Patatin-like phospholipase] 
[4.2e-27] 
1 0 2 0 
A174L 7453 12.2 N/A Unknown protein 2 0 0 0 
A176L 9167 11.3 N/A Unknown protein; PfamA: PF08789.3 
[PBCV-specific basic adaptor domain] [9e-
12] 
1&2 0 0 0 
A188aR 17326 10.0 N/A COG0417 [DNA polymerase elongation 
subunit (family B)] [3e-07]; PfamA: 
PF00136.14 [DNA polymerase family B] 
[6.5e-17] 
1 0 0 0 
A189/192R 143575 11.4 Late Unknown protein 1&2 0 0 0 
A196L 17456 8.4 Late Unknown protein 2 3 3 1 
A201aL 6787 8.8 N/A Unknown protein 1 0 0 0 
A201L 10005 10.7 Early-Late Unknown protein 1 2 2 2 
A202L 12232 5.0 Early-Late Unknown protein 2 0 0 0 
A203R 24011 6.0 Late Unknown protein 1&2 1 2 0 
A205R 22452 12.1 Late Unknown protein; PfamA: PF08789.3 
[PBCV-specific basic adaptor domain] 
[4.2e-16] 
1&2 0 0 0 
A213L 16483 4.5 Early-Late Unknown protein 1&2 1 1 1 
A217L 45248 9.9 Early-Late Unknown protein 1&2 0 0 1 
A219/222/226R 77797 7.0 Early COG1215 [Glycosyltransferases probably 
involved in cell wall biogenesis] [4e-06]; 
Swissprot: P58932 [RecName: FullCellulose 
synthase catalytic subunit (UDP-forming)] 
1 9 8 10 
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[6e-07] 
A227L 15689 10.0 Late Unknown protein 1&2 0 0 0 
A230R 22055 8.4 Late Unknown protein 1&2 4 4 4 
A231L 43644 9.9 Early-Late Unknown protein 1&2 1 0 0 
A237R 58565 9.5 Late Homospermidine synthase 1&2 0 0 0 
A245R 19748 9.3 Late Cu/Zn superoxide dismutase 1&2 1 1 0 
A246R 12017 11.5 Late Unknown protein 1&2 0 0 0 
A252R 39856 10.3 Early R.CviAII restriction endonuclease 1&2 0 0 0 
A255R 17300 5.1 N/A Unknown protein 1 0 0 0 
A256/257L 96729 7.2 Early-Late Unknown protein 1 0 0 0 
A260aR 7742 11.9 N/A Unknown protein 1 0 0 0 
A262/263L 29470 9.6 N/A Unknown protein 1&2 2 3 2 
A271L 31114 7.1 Early-Late COG2267 [Lysophospholipase] [1e-07] 1 0 3 0 
A273L 15713 9.9 Late PF03713.6 [Domain of unknown function 
(DUF305)] [6.8e-13] 
1 3 3 3 
A278L 69231 10.8 Late Protein kinase; PfamA: PF00069.18 [Protein 
kinase domain] [1.2e-07] / PF08789.3 
[PBCV-specific basic adaptor domain] 
[7.5e-10] 
1&2 0 1 0 
A282L 63371 10.8 Late Protein kinase; PfamA: PF00069.18 [Protein 
kinase domain] [1.2e-07] / PF08789.3 
[PBCV-specific basic adaptor domain] 
[1.3e-17] 
1&2 0 1 0 
A284L 30766 9.2 Early-Late Amindase 1&2 0 0 0 
A286R 43042 9.6 Late Unknown protein 1&2 0 0 0 
A287R 31349 9.4 Early-Late PfamA: PF01541.17 [GIY-YIG catalytic 
domain] [4.2e-11] / PF07453.6 [NUMOD1 
domain] [8.6e-11] 
1 0 0 0 
A295L 35626 7.9 Early-Late Fucose synthetase; Swissprot: Q9LMU0 
[RecName: FullPutative GDP-L-fucose 
synthase 2 AltName: FullGDP-4-keto-6-
deoxy-D-mannose-3 5-epimerase-4-
reductase 2 ShortAtGER2] [1e-100] 
1 0 0 0 
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A296R 17393 12.2 Late Unknown protein 1&2 0 1 1 
A304R 9490 5.8 Late Unknown protein 1 0 0 0 
A305L 22910 10.7 Late Protein phosphatase; Swissprot: Q9BY84 
[RecName: FullDual specificity protein 
phosphatase 16 AltName: FullMitogen-
activated protein kinase phosphatase 7 
ShortMAP kinase phosphatase 7 ShortMKP-
7] [7e-12] 
1&2 0 0 0 
A310L 18268 8.5 Late Unknown protein 1&2 0 0 0 
A314R 9114 6.7 Late Unknown protein 1&2 1 1 1 
A316R 48779 10.7 Late Unknown protein 1&2 0 1 0 
A320R 15685 10.5 Late Unknown protein 1&2 1 1 1 
A321R 12830 8.8 Late Unknown protein 1 2 2 2 
A322L 20039 5.0 Late Unknown protein 1&2 1 1 1 
A339L 7372 11.1 Early-Late Unknown protein 1 0 0 0 
A342L 63813 9.2 Early-Late Unknown protein 1&2 1 1 1 
A349L 21077 10.0 Early-Late Unknown protein 1&2 0 1 0 
A350R 14676 9.7 N/A PfamA: PF12239.1 [Protein of unknown 
function (DUF3605)] [4.4e-23] 
2 0 0 0 
A352L 23310 3.6 Late Swissprot: Q5UQF7 [RecName: 
FullUncharacterized protein R489 Flags: 
Precursor] [1e-05] 
1&2 0 1 1 
A356R 12512 10.5 N/A Unknown protein 1 0 0 0 
A363R 128448 10.9 Early Swissprot: P0C9B2 [RecName: FullPutative 
ATP-dependent RNA helicase Q706L] [2e-
06] 
1&2 0 2 0 
A375R 19085 9.4 Early-Late Unknown protein 1&2 2 2 2 
A378L 29219 9.4 Late Unknown protein 1&2 1 1 0 
A383R 52511 5.2 Late Capsid protein; Pfam: PF04451.5 [Large 
eukaryotic DNA virus major capsid protein] 
[1.6e-25] 
1&2 0 0 0 
A384bL 6809 9.0 N/A Unknown protein 2 1 1 1 
A384dL 69009 8.0 Early-Late Capsid protein; PfamA: PF01607.17 [Chitin 
binding Peritrophin-A domain] [2.4e-07] / 
PF04451.5 [Large eukaryotic DNA virus 
1&2 1 2 1 
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major capsid protein] [2e-11] 
A398L 12987 9.9 Late Unknown protein 1&2 2 3 3 
A400R 13634 9.5 Early-Late Unknown protein 2 0 0 0 
A405R 53502 10.3 Late Unknown protein 1&2 1 2 1 
A407L 23382 8.9 Late Unknown protein 1&2 1 2 2 
A413L 26998 9.5 Late Unknown protein 1&2 2 2 2 
A414R 10612 10.8 Late Unknown protein 1&2 2 2 2 
A420L 7918 6.4 Late Unknown protein 2 1 1 1 
A421R 11056 10.1 Late Unknown protein 1&2 1 1 1 
A423R 18458 6.5 Late Unknown protein 2 0 1 0 
A430L 48165 7.5 Late Major capsid protein 1&2 0 0 0 
A436L 6932 13.0 N/A Unknown protein; Pfam: PF08789.3 [PBCV-
specific basic adaptor domain] [1.5e-16] 
1 0 0 0 
A437L 10876 11.0 Late PfamA: PF05854.4 [Non-histone 
chromosomal protein MC1] [5.9e-07] 
1&2 0 1 0 
A438L 8988 10.7 Early-Late Glutaredoxin 2 0 0 0 
A440L 10112 11.1 Early Unknown protein 1&2 0 0 0 
A443R 34961 5.3 Early Unknown protein 1 0 0 0 
A448L 12369 10.4 Late Protein disulphide isomerase with heme 
binding site 
1&2 0 0 0 
A454L 31194 4.7 Early-Late Unknown protein 1&2 1 1 0 
A456L 75235 5.5 Early COG3378 [Predicted ATPase] [3e-06]; 
PfamA: PF08706.4 [D5 N terminal like] 
[3.9e-09] 
1 0 0 0 
A465R 13528 10.2 Early-Late COG5054 [Mitochondrial sulfhydryl oxidase 
involved in the biogenesis of cytosolic Fe/S 
proteins] [4e-06]; PfamA: PF04777.6 [Erv1 / 
Alr family] [3.5e-22] 
1&2 0 0 0 
A476R 37393 4.4 Early-Late Swissprot: Q6Y657 [RecName: FullPutative 
ribonucleoside-diphosphate reductase small 
chain B AltName: FullRibonucleotide 
reductase small subunit B AltName: 
FullRibonucleoside-diphosphate reductase 
1 0 0 1 
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R2B subunit] [1e-113] 
A480L 9838 10.0 Late Unknown protein 1&2 2 2 2 
A484L 18604 9.6 Early-Late Unknown protein 1&2 0 0 0 
A488R 34631 5.0 Late Swissprot: Q5UQL4 [RecName: 
FullUncharacterized protein L417] [2e-09] 
1&2 0 3 0 
A497R 15378 10.4 Late Unknown protein 1&2 2 2 1 
A500L 38463 5.0 N/A Unknown protein 1&2 1 2 1 
A502L 11069 9.4 Late Unknown protein 2 1 1 1 
A520L 11674 10.7 Late Unknown protein 2 0 0 0 
A521aL 22578 6.3 N/A Swissprot: O55742 [RecName: 
FullUncharacterized protein 136R] [2e-07] 
1&2 0 0 0 
A521L 23738 11.4 Early-Late Unknown protein 1&2 0 0 0 
A523R 19096 9.6 Late Unknown protein 1&2 0 0 0 
A526R 16434 9.3 Late Unknown protein 1&2 0 1 0 
A527R 11605 10.7 Late Unknown protein 1&2 0 0 0 
A531L 7670 7.5 Late Unknown protein 2 1 1 1 
A532aL 5479 4.5 N/A Unknown protein 2 1 1 1 
A532L 8698 9.7 Late Unknown protein 1&2 1 1 1 
A533R 40132 3.8 Early-Late Unknown protein 1&2 0 0 0 
A534R 11783 9.7 N/A Unknown protein 1&2 0 0 0 
A535L 8210 4.7 Early-Late Unknown protein 1&2 0 0 0 
A536L 8485 10.0 Early-Late Unknown protein 1&2 1 1 0 
A540L 127197 6.2 Late Unknown protein 1 0 0 0 
A548L 57432 9.5 Early PfamA: PF00176.16 [SNF2 family N-
terminal domain] [6.7e-34] / PF00271.24 
[Helicase conserved C-terminal domain] 
[1.5e-10] 
1 0 0 0 
A558L 45547 5.1 Early-Late Capsid protein; PfamA: PF04451.5 [Large 
eukaryotic DNA virus major capsid protein] 
[6.6e-60] 
1&2 0 0 0 
A559L 24034 10.2 Late Unknown protein 1&2 1 1 0 
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A561L 71004 9.9 Late Unknown protein 1&2 1 2 1 
A565R 73169 7.3 Early-Late Unknown protein 1&2 1 1 1 
A567L 17418 10.1 Early-Late Unknown protein 1 0 0 0 
A571R 12972 12.0 Late Pfam hit: PF08789.3 [PBCV-specific basic 
adaptor domain] [5.7e-17]; Refseq best hit: 
YP_001426112 [hypothetical protein 
FR483_N480R (Paramecium bursaria 
Chlorella virus FR483)] [3e-39] 
1 0 0 0 
A572R 20606 7.1 Late Unknown protein 1&2 0 0 0 
A577L 15442 11.0 Late Unknown protein 1&2 0 0 0 
A579L 27445 10.1 Late R.CviAI restriction endonuclease 1&2 0 0 0 
A586R 8567 11.8 N/A Unknown protein 1 0 0 0 
A598L 41558 6.9 Early-Late COG0076 [Glutamate decarboxylase and 
related PLP-dependent proteins] [5e-06]; 
PfamA: PF00282.12 [Pyridoxal-dependent 
decarboxylase conserved domain] [1.1e-17] 
1 0 0 0 
A605L 17769 10.9 Early-Late Unknown protein 1&2 1 1 1 
A612L 13587 8.7 Late Histone H3K27 methylase 2 0 0 0 
A614L 64733 11.2 Late Protein kinase; PfamA: PF00069.18 [Protein 
kinase domain] [5.6e-11] 
1&2 0 0 0 
A617R 37586 9.9 Early-Late Swissprot: Q5UQJ6 [RecName: FullPutative 
serine/threonine-protein kinase R400] [7e-
12] 
1 0 0 0 
A621L 12935 9.5 Late Unknown protein 1 2 2 2 
A622L 58097 5.7 Late Capsid protein; PfamA: PF04451.5 [Large 
eukaryotic DNA virus major capsid protein] 
[1.7e-66] 
1&2 0 0 0 
A624R 13570 9.3 Late Unknown protein; PfamA: PF09945.2 
[Predicted membrane protein (DUF2177)] 
[3.4e-26] 
1 3 4 3 
A625R 49945 10.7 Late COG0675 [Transposase and inactivated 
derivatives] [1e-06]; PfamA: PF12323.1 
[Helix-turn-helix domain] [1.4e-06] / 
PF07282.4 [Putative transposase DNA-
binding domain] [6.7e-18] 
1 0 0 0 
A627R 49629 11.1 Late Unknown protein 1&2 1 3 0 
Page 47 of 47 
 
A629R 86292 7.5 Early-Late PfamA: PF03477.9 [ATP cone domain] 
[8.5e-15] / PF00317.14 [Ribonucleotide 
reductase all-alpha domain] [7.9e-19] / 
PF02867.8 [Ribonucleotide reductase barrel 
domain] [2e-194] 
1 0 0 0 
A631L 10392 9.9 N/A Unknown protein 1 0 0 0 
A643R 53097 11.3 Late Unknown protein 1&2 0 0 0 
A644R 19207 6.0 Late Unknown protein 1&2 0 0 0 
A655L 12002 11.4 N/A Unknown protein 1 0 1 0 
A676R 42432 10.6 Late Unknown protein; PfamA: PF08789.3 
[PBCV-specific basic adaptor domain] 
[1.9e-17] / PF08793.3 [2-cysteine adaptor 
domain] [1.8e-15] 
1&2 0 0 0 
A678R 41287 10.3 Late Unknown protein 1&2 0 3 0 
A686L 18316 6.9 Early Unknown protein 1 0 1 0 
a – Transmembrane regions of the protein were predicted by TMHMM [T] (30), HMMTOP [H] (50), and Phobius [P] (20) methods. 867 
For all the method default parameters were used for the prediction. The number shown in the table is the number of helixes predicted 868 
by the method. 869 
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